SuspendedNCT04896827

Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC) Using Deep Learning and Artificial Intelligence

Sponsor: Université de Sherbrooke

Trial Details

ConditionChronic Pain
InterventionConditioned pain modulation test
StatusSuspended
Participants244
Est. Completion1 Dec 2028
Last Updated28 May 2026

Primary Outcome

Conditioned pain modulation (CPM) profiles; Temporal summation profiles

Eligibility Criteria

Inclusion Criteria

Healthy participants Inclusion Criteria: * 18-79 years old * No chronic pain * Able to provide consent Exclusion Criteria: * Cardiovascular disease (arrhythmia, cerebrovascular accident, infarction...) * Raynaud syndrome * Severe psychiatric disease (dementia, schizophrenia, psychosis, major depression) * Injuries or loss sensitivity to their forearms or hands * Pregnant women or in post-partum period (\<1 year) Participants with chronic pain Inclusion Criteria: * 18-79 years old * Chronic pain (chronic pain is defined by any regular pain for more than 6 months) * Able to provide consent Exclusion Criteria: * Cardiovascular disease (arrhythmia, cerebrovascular accident, infarction...) * Raynaud syndrome * Severe psychiatric disease (dementia, schizophrenia, psychosis, major depression) * Injuries or loss sensitivity to their forearms or hands * Pregnant women or in post-partum period (\<1 year) * Chronic pain caused by cancer or migraine

Trial Sites

Countries

Canada
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service